Sophiris Bio, Inc. (SPHS)


Stock Price Forecast

May 22, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Sophiris Bio, Inc. chart...

About the Company

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The firm develops PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

Sector

Health Technology

Industry

Biotechnology

Employees

6

$5M

Total Revenue

6

Employees

$0M

Market Capitalization

-0.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SPHS News

TRML Tourmaline Bio, Inc.

3d ago, source: Seeking Alpha

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops TOUR006, a human anti-IL-6 monoclonal ...

Gossamer Bio Inc GOSS

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

bluebird bio, Inc. (BLUE)

8d ago, source: Yahoo Finance

SOMERVILLE, Mass., March 11, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio") today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA™ (lovotibeglogene ...

Passage Bio, Inc. Common Stock (PASG)

4y ago, source: Nasdaq

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Palisade Bio, Inc.

3y ago, source: CNN

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post ...

Bio Inc. Redemption | Console Release Announcement Trailer

1mon ago, source: Hosted on MSN

Bio Inc. Redemption is a realistic simulation and strategy game developed by DryGin Studios. Players have the ability and ultimate autonomy to cure their human patients or create a deadly illness.

NUUU Rejuvel Bio-Sciences, Inc.

5d ago, source: Seeking Alpha

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

4d ago, source: U.S. News & World Report

Advice, rankings and one great story every day. Some funds make more sense to hold in a Roth IRA due to higher income generation, greater turnover or the potential for stronger long-term growth.

Generation Bio Inc.

1y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

bluebird bio, Inc.

1mon ago, source: CNN

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...